Skip to main navigation Skip to search Skip to main content

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate to Severe Ulcerative Colitis.

  • Sparrow, Miles (Primary Chief Investigator (PCI))
  • McKenzie, Jo (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date6/10/20 → 31/12/23

Keywords

  • Gastroenterology
  • Ulcerative colitis
  • Clinical trial

Clinical Trial Phase

  • Phase II